Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.310
+0.050 (2.21%)
Aug 19, 2026, 9:51 AM EDT - Market open
Pulmonx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 55.84 | 69.75 | 70.91 | 83.55 | 101.74 | 148.48 |
Short-Term Investments | - | - | 30.58 | 33.56 | 39.4 | 31.56 |
Cash & Short-Term Investments | 55.84 | 69.75 | 101.48 | 117.1 | 141.14 | 180.04 |
Cash Growth | -33.70% | -31.27% | -13.34% | -17.03% | -21.61% | -22.25% |
Accounts Receivable | 12.25 | 12.07 | 13.12 | 12.11 | 8.68 | 6.56 |
Other Receivables | 0.48 | 0.59 | 0.67 | 0.92 | 0.6 | 0.36 |
Receivables | 12.73 | 12.66 | 13.79 | 13.02 | 9.28 | 6.92 |
Inventory | 16.39 | 15.85 | 16.92 | 16.74 | 14.56 | 16.29 |
Prepaid Expenses | 2.88 | 2.68 | 2.67 | 2.82 | 3.45 | 4.17 |
Restricted Cash | 0.26 | 0.26 | 0.26 | 0.24 | 0.23 | 0.23 |
Other Current Assets | 0.03 | 0.49 | 1.13 | 0.5 | 0.29 | 0.35 |
Total Current Assets | 88.13 | 101.68 | 136.25 | 150.42 | 168.95 | 208 |
Property, Plant & Equipment | 19.15 | 20.25 | 21.45 | 7.43 | 10.5 | 12.89 |
Long-Term Investments | - | - | - | 14.39 | 5.92 | 10.94 |
Goodwill | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
Other Intangible Assets | 0.6 | 0.7 | - | 0.03 | 0.15 | 0.28 |
Other Long-Term Assets | 4.51 | 4.33 | 2.82 | 3.17 | 5.81 | 0.73 |
Total Assets | 114.73 | 129.29 | 162.85 | 177.78 | 193.68 | 235.17 |
Accounts Payable | 4.68 | 3.91 | 3.83 | 1.5 | 1.76 | 1.58 |
Accrued Expenses | 14.07 | 14.56 | 16.47 | 16.23 | 13.28 | 13.37 |
Current Portion of Long-Term Debt | 0.1 | 0.11 | 3.18 | 2.16 | 0.09 | 0.09 |
Current Portion of Leases | 1.28 | 1.21 | 0.78 | 3.07 | 3.23 | 2.2 |
Current Income Taxes Payable | 0.26 | 0.26 | 0.05 | 0.09 | 0.02 | 0.15 |
Current Unearned Revenue | 0.02 | 0.02 | 0.14 | 0.1 | 0.12 | 0.16 |
Total Current Liabilities | 20.41 | 20.06 | 24.44 | 23.16 | 18.49 | 17.55 |
Long-Term Debt | 37.43 | 36.99 | 34 | 35.09 | 17.23 | 17.32 |
Long-Term Leases | 17.4 | 18.06 | 18.52 | 1.11 | 3.85 | 6.84 |
Long-Term Deferred Tax Liabilities | 0.06 | 0.07 | 0.09 | 0.11 | 0.09 | 0.04 |
Other Long-Term Liabilities | 0.24 | - | - | - | - | 0.18 |
Total Liabilities | 75.54 | 75.18 | 77.04 | 59.47 | 39.67 | 41.93 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Additional Paid-In Capital | 582.4 | 573.27 | 551.21 | 526.8 | 502.71 | 482.89 |
Retained Earnings | -545.29 | -521.56 | -467.56 | -411.16 | -350.32 | -291.4 |
Comprehensive Income & Other | 2.05 | 2.36 | 2.11 | 2.64 | 1.58 | 1.71 |
Total Common Equity | 39.2 | 54.12 | 85.81 | 118.32 | 154.01 | 193.24 |
Shareholders' Equity | 39.2 | 54.12 | 85.81 | 118.32 | 154.01 | 193.24 |
Total Liabilities & Equity | 114.73 | 129.29 | 162.85 | 177.78 | 193.68 | 235.17 |
Total Debt | 56.21 | 56.36 | 56.47 | 41.42 | 24.4 | 26.46 |
Net Cash (Debt) | -0.37 | 13.39 | 45.01 | 90.07 | 122.66 | 164.52 |
Net Cash Growth | - | -70.26% | -50.03% | -26.57% | -25.45% | -19.48% |
Net Cash Per Share | -0.01 | 0.33 | 1.15 | 2.37 | 3.31 | 4.55 |
Filing Date Shares Outstanding | 42.95 | 42.24 | 39.8 | 38.54 | 37.65 | 37.02 |
Total Common Shares Outstanding | 42.95 | 41.67 | 39.79 | 38.52 | 37.56 | 36.93 |
Working Capital | 67.73 | 81.63 | 111.81 | 127.27 | 150.46 | 190.45 |
Book Value Per Share | 0.91 | 1.30 | 2.16 | 3.07 | 4.10 | 5.23 |
Tangible Book Value | 36.26 | 51.08 | 83.48 | 115.95 | 151.52 | 190.63 |
Tangible Book Value Per Share | 0.84 | 1.23 | 2.10 | 3.01 | 4.03 | 5.16 |
Machinery | 6.63 | 6.48 | 6.11 | 4.41 | 4.15 | 3.45 |
Construction In Progress | 0 | 0.05 | 0.21 | 2.2 | 1.83 | 1.33 |
Leasehold Improvements | 2.34 | 2.34 | 2.32 | 2.28 | 2.28 | 2.28 |